{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:36:25Z","timestamp":1791088585777,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":5436,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1186\/2110-5820-1-30","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T14:24:03Z","timestamp":1312295043000},"page":"30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients"],"prefix":"10.1016","volume":"1","author":[{"given":"Argyris S","family":"Michalopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E","family":"Falagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/2110-5820-1-30_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria","volume":"25","author":"Li","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/2110-5820-1-30_bb0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-5347(17)61924-4","article-title":"Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals","volume":"103","author":"Froman","year":"1970","journal-title":"J Urol"},{"key":"10.1186\/2110-5820-1-30_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0972-5229.56048","article-title":"Colistin and polymyxin B: a re-emergence","volume":"13","author":"Gupta","year":"2009","journal-title":"Indian J Crit Care Med"},{"key":"10.1186\/2110-5820-1-30_bb0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1186\/2110-5820-1-30_bb0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkl512","article-title":"In vitro pharmaco-dynamics of colistin against Acinetobacter baumannii clinical isolates","volume":"59","author":"Owen","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0035","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dkn425","article-title":"In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae","volume":"62","author":"Poudyal","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0040","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Hetero-resistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jac\/dkm511","article-title":"Comparison of once-, twice- and thrice daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","volume":"61","author":"Bergen","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0050","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/AAC.00903-09","article-title":"Pharmacokinetic (PK)\/Pharmacodynamic (PD) investigation of colistin (C) against Pseudomonas aeruginosa (Pa) using an in vitro model","volume":"54","author":"Bergen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0055","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.10-0463","article-title":"Steady-state pharmacokinetics and bronchoalveolar lavage concentration of colistin in critically-ill patients after intravenous colistin methanesulphonate administration","volume":"138","author":"Imberti","year":"2010","journal-title":"Chest"},{"key":"10.1186\/2110-5820-1-30_bb0060","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/AAC.01114-09","article-title":"Elucidation of the pharmacokinetic\/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models","volume":"54","author":"Dudhani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0065","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/jac\/dkq226","article-title":"fAUC\/MIC is the most predictive pharmacokinetic\/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models","volume":"65","author":"Dudhani","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clinthera.2008.01.015","article-title":"Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study","volume":"30","author":"Markou","year":"2008","journal-title":"Clin Ther"},{"key":"10.1186\/2110-5820-1-30_bb0075","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/AAC.01361-08","article-title":"Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically-ill patients with infections caused by gram-negative bacteria","volume":"53","author":"Plachouras","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1179\/joc.2010.22.3.175","article-title":"Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use","volume":"22","author":"Daikos","year":"2010","journal-title":"J Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0085","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AAC.49.11.4814-4815.2005","article-title":"Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration","volume":"49","author":"Li","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/jac\/dki461","article-title":"Pharmacokinetics of inhaled colistin in patients with cystic fibrosis","volume":"57","author":"Ratjen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0095","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00134-010-1879-4","article-title":"Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa","volume":"6","author":"Lu","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1186\/2110-5820-1-30_bb0100","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1086\/517243","article-title":"Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium","volume":"28","author":"Fern\u00e1ndez-Viladrich","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1186\/2110-5820-1-30_bb0105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3171\/jns.2005.102.5.0915","article-title":"Intrathecal colistin for treatment of highly resistant Pseudomonas ventriculitis: case report and review of the literature","volume":"102","author":"Gump","year":"2005","journal-title":"J Neurosurg"},{"key":"10.1186\/2110-5820-1-30_bb0110","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1345\/aph.1E485","article-title":"Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection","volume":"39","author":"Quinn","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1186\/2110-5820-1-30_bb0115","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/AAC.00345-09","article-title":"Penetration of colistin into cerebrospinal fluid","volume":"53","author":"Markantonis","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/2110-5820-1-30_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2009.10.005","article-title":"Colistin therapy for microbiologically documented multidrug-resistant Gram (-) bacterial infections: a retrospective cohort study of 258 patients","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/2110-5820-1-30_bb0125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijantimicag.2005.09.004","article-title":"Nephrotoxicity of intravenous colistin: a prospective evaluation","volume":"26","author":"Falagas","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/2110-5820-1-30_bb0130","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/00365540903147001","article-title":"Nephrotoxicity associated with the use of intravenous colistin","volume":"41","author":"Santamar\u00eda","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1186\/2110-5820-1-30_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2009.11.016","article-title":"Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections","volume":"35","author":"Cheng","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/2110-5820-1-30_bb0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijid.2006.09.011","article-title":"Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand","volume":"11","author":"Koomanachai","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1186\/2110-5820-1-30_bb0145","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijantimicag.2009.06.028","article-title":"Clinical characteristics and risk factors of colistin-induced nephrotoxicity","volume":"34","author":"Kim","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/2110-5820-1-30_bb0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00431-009-1137-3","article-title":"Colistin administration to pediatric and neonatal patients","volume":"169","author":"Iosifidis","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1186\/2110-5820-1-30_bb0155","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1442-200X.2009.03015.x","article-title":"Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients","volume":"52","author":"Celebi","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1186\/2110-5820-1-30_bb0160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e3182064bfe","article-title":"Intravenous colistin administration in neonates","volume":"30","author":"Jajoo","year":"2011","journal-title":"Pediatr Infect Dis J"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2110-5820-1-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2110-5820-1-30\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025015092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025015092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2110-5820-1-30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:19:05Z","timestamp":1776669545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025015092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"alternative-id":["S2110582025015092"],"URL":"https:\/\/doi.org\/10.1186\/2110-5820-1-30","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/2110-5820-1-30","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Michalopoulos and Falagas; licensee Springer. 2011. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"30"}}